DaVita Inc. $DVA Shares Sold by BNP PARIBAS ASSET MANAGEMENT Holding S.A.

Key Points

• BNP PARIBAS ASSET MANAGEMENT Holding S.A. has reduced its stake in DaVita Inc. by 19.6%, now owning 106,490 shares valued at approximately $16.3 million.
• In contrast, other institutional investors, such as UMB Bank and National Pension Service, significantly increased their holdings in DaVita during the same period, reflecting mixed sentiments among major stakeholders.
• DaVita recently reported earnings that exceeded analyst expectations, with an EPS of $2.95 for the quarter, indicating a 6.1% increase in revenue year-over-year.

BNP PARIBAS ASSET MANAGEMENT Holding S.A. reduced its stake in DaVita Inc. (NYSE:DVA - Free Report) by 19.6% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 106,490 shares of the company's stock after selling 25,979 shares during the quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. owned 0.14% of DaVita worth $16,289,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently modified their holdings of DVA. Epoch Investment Partners Inc. purchased a new position in shares of DaVita in the 4th quarter valued at approximately $55,100,000. Iron Triangle Partners LP purchased a new position in shares of DaVita in the 4th quarter valued at approximately $38,946,000. GAMMA Investing LLC boosted its stake in shares of DaVita by 14,695.8% in the first quarter. GAMMA Investing LLC now owns 234,809 shares of the company's stock valued at $35,919,000 after buying an additional 233,222 shares in the last quarter. Northern Trust Corp boosted its stake in shares of DaVita by 20.2% in the first quarter. Northern Trust Corp now owns 890,632 shares of the company's stock valued at $136,240,000 after buying an additional 149,858 shares in the last quarter. Finally, Nuveen LLC purchased a new stake in shares of DaVita in the first quarter valued at approximately $20,218,000. 90.12% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at DaVita

In related news, insider James O. Hearty sold 2,351 shares of DaVita stock in a transaction on Wednesday, July 23rd. The stock was sold at an average price of $150.00, for a total transaction of $352,650.00. Following the completion of the transaction, the insider directly owned 26,038 shares of the company's stock, valued at approximately $3,905,700. The trade was a 8.28% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Corporate insiders own 1.50% of the company's stock.

Analysts Set New Price Targets

A number of research firms recently weighed in on DVA. Barclays decreased their price target on DaVita from $169.00 to $160.00 and set an "equal weight" rating on the stock in a research note on Thursday, August 7th. Truist Financial set a $148.00 price target on DaVita in a research note on Friday, August 8th. Finally, Wall Street Zen upgraded DaVita from a "hold" rating to a "buy" rating in a research note on Friday, April 25th. Three investment analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, DaVita currently has a consensus rating of "Hold" and a consensus target price of $164.00.

DaVita Price Performance

DVA stock traded up $0.8090 during midday trading on Wednesday, hitting $137.4890. 467,021 shares of the stock were exchanged, compared to its average volume of 915,291. The stock's 50-day moving average price is $139.54 and its 200-day moving average price is $144.65. The stock has a market cap of $9.83 billion, a price-to-earnings ratio of 13.52, a PEG ratio of 0.98 and a beta of 1.09. DaVita Inc. has a fifty-two week low of $126.07 and a fifty-two week high of $179.60. The company has a debt-to-equity ratio of 23.18, a quick ratio of 1.34 and a current ratio of 1.39.

DaVita (NYSE:DVA - Get Free Report) last issued its quarterly earnings data on Tuesday, August 5th. The company reported $2.95 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.70 by $0.25. The firm had revenue of $3.38 billion during the quarter, compared to analysts' expectations of $3.36 billion. DaVita had a return on equity of 369.39% and a net margin of 6.35%.DaVita's revenue was up 6.1% on a year-over-year basis. During the same period in the previous year, the firm posted $2.00 earnings per share. DaVita has set its FY 2025 guidance at 10.200-11.300 EPS. Research analysts predict that DaVita Inc. will post 10.76 earnings per share for the current year.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.